Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- Check4 days agoChange DetectedRevision label on the page updated from v3.5.0 to v3.5.2, reflecting a minor site update rather than changes to study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed. This update does not modify the study details or page content.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.2 was added to the page, and the older operating-status notice (Revision: v3.4.1) was removed.SummaryDifference0.4%

- Check76 days agoChange DetectedAdded a government funding status notice and updated the site revision tag to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a glossary toggle and updated QC-related metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older label 'Last Update Submitted that met QC Criteria' and standardizing capitalization such as 'No FEAR Act data' across the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.